![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 33, 22907-22910, August 13, 1999
From the Tartrate-resistant acid phosphatase
(TRAP) is highly expressed in bone-resorbing osteoclasts and activated
macrophages. It has been suggested that a redox-active iron in the
binuclear iron center of TRAP could have the capacity to react with
hydrogen peroxide to produce highly destructive reactive oxygen species (ROS). Here we show that TRAP can generate ROS in vitro and
that cells over-expressing TRAP produce higher amounts of intracellular ROS than their parent cells. We further demonstrate that these ROS can
be targeted to destroy collagen and other proteins. In resorbing
osteoclasts, TRAP was found in transcytotic vesicles transporting
matrix degradation products through the cell, suggesting that
TRAP-facilitated fragmentation of endocytosed material takes place in a
specific cellular compartment. These results suggest that bone matrix
degradation occurs not only extracellularly in the resorption lacunae
but also intracellularly in the transcytotic vesicles. We propose that
proteins containing redox-active iron could represent a novel mechanism
of physiological fragmentation of organic molecules. This mechanism
could be important in tissue remodeling and as a defense mechanism of
phagocytosing cells.
During bone growth and remodeling, a remarkable amount of bone is
degraded by osteoclasts that have developed an efficient machinery to
break down inorganic and organic bone matrix (1). Crucial components of
this machinery are the secretions of acid and proteinases into an
extracellular resorption lacuna (2-5). Resorbing osteoclasts are
highly polarized and reveal at least four different membrane domains
(5). Ruffled border (RB)1
forms the actual resorbing organ and penetrates into bone matrix with
continuous endocytosis and transcytosis of degraded matrix components
(6, 7). Finally, resorption products are secreted to the extracellular
space via a functional secretory domain (FSD) in the basolateral
membrane (8). In addition to active acidification and production of
various proteinases, osteoclasts produce high amounts of reactive
oxygen species (ROS) during resorption (9). However, the source and
exact role of ROS have remained unclear.
Tartrate-resistant acid phosphatase (TRAP) is widely used as a specific
marker for osteoclasts (10). High amounts of TRAP are also expressed in
lung macrophages and in the hairy cells of the spleen in hairy cell
leukemia (11). TRAP contains a binuclear iron center (12, 13), which
has been suggested to participate in the generation of hydroxyl
radicals (·OH) (14, 15). The function and subcellular
localization of TRAP have remained unclear despite extensive
biochemical characterization and production of knock-out animals. Aging
TRAP Detection of Hydroxyl Radicals--
Hydroxyl radical formation
was monitored by following the formation of malondialdehyde acetal
(MDA) from deoxyribose as described earlier (17). Recombinant rat bone
TRAP (18, 19) was incubated for 1 h at 37 °C in a 1.0-ml
reaction mixture containing 10 mM deoxyribose, 0.1 mM ascorbate, 1 mM hydrogen peroxide, 5 µg (1 unit) of aprotinin, and 1 mM phenylmethylsulfonyl fluoride
in phosphate-buffered saline, pH 7.2. Ferric EDTA (0.1 mM
FeCl3 in 0.2 mM EDTA) was used as a positive
control and transferrin, carbonic anhydrase II (CA II), and matrix
metalloproteinase 9 (MMP-9) as negative controls. Formation of
·OH was further studied by adding various amounts of mannitol, a
scavenger of ·OH (17), to the reaction mixture containing TRAP.
Color was developed by heating for 15 min at 100 °C in
thiobarbituric acid and trichloroacetic acid as described (17).
Over-expression of TRAP--
The Pg-TRAP plasmid was constructed
by cloning reverse transcriptase-polymerase chain reaction-cloned TRAP
cDNA from human osteoclast-like cells into pCI Neo mammalian
expression vector (Promega, Madison, WI) at the EcoRI site.
This construct was transfected into murine macrophage-like RAW-264
cells using a cationic liposome reagent (Roche Molecular Biochemicals).
Transfected cells were selected with 400 mg/ml geneticin (G418,
Calbiochem-Novabiochem, San Diego, CA) over 14 days. Isolated clones
were maintained in 200 mg/ml geneticin.
Measurement of Intracellular Oxidized State--
Intracellular
ROS were detected using the fluorescent probe DCFH-DA (Molecular
Probes, Eugene, OR) (20). Cells were grown on glass coverslips,
incubated for 5 min in Hanks' solution (Life Technologies Inc.)
containing 5 mM DCFH-DA, briefly rinsed in Hanks'
solution, and kept at +37 °C during the measurement. Cells were
excited with a 495 nm wavelength using a computer-driven filter wheel
(MAC 2000, Ludl Electronic Products, New York) and a 32D neutral filter
to avoid UV-induced radical production. Emitted light was collected
through a dichroic mirror and an interference filter at 510 nm.
Fluorescence was quantitated using an MCID image analyzer utilizing M2
software (Imaging research Inc., Brock University, Ste. Catharines,
Ontario, Canada) as described (21).
Osteoclast Culture and Immunofluorescence Microscopy--
Rat
bone cells were cultured for 24 h on bovine bone slices as
described (22) and fixed with 3% paraformaldehyde containing 0.2%
Triton X-100. Cells were incubated with mouse TRAP antiserum (1:1000 in
0.5% bovine serum albumin/Tris-buffered saline) for 2 h (23).
TRAP was visualized using rhodamine-conjugated anti-mouse IgG
(Dakopatts, Glostrup, Denmark). RB was visualized using fluorescein isothiocyanate-labeled PNA-lectin (Sigma) (24). Biotinylated organic
bone matrix components were visualized as described (7). Bone slices
were washed, embedded with 50% glycerol, and examined under a light
microscope equipped with appropriate filters (Leitz Aristoplan,
Wetzlar, Germany). Fluorescent images were photographed on Agfa Pan 400 film. Confocal microscopy was performed using confocal laser scanning
microscope (Leica Lasertechnic, Heidelberg, Germany) equipped with a
multiline 750-milliwatt Omnichrome argon-krypton laser (Omnichrome,
Chino. CA).
Monitoring of Collagen Breakdown--
Type I collagen (Fluka,
Buchs, Switzerland) was purified from low molecular weight impurities
by gel filtration using Superdex 200 HR 10/30 gel filtration column
equilibrated with 10 mM Tris-HCl, pH 8.2, containing 0.3 M NaCl, using HPLC equipment (Amersham Pharmacia Biotech).
100 µg of the purified collagen was incubated for 1 h at
37 °C in a reaction mixture containing 80 nM TRAP, 0.1 mM ascorbate, 1 mM hydrogen peroxide, 5 µg (1 unit)/ml aprotinin, and 1 mM phenylmethylsulfonyl fluoride
in phosphate-buffered saline, pH 7.2. After the reaction, a 0.5-ml
aliquot was immediately chromatographed through Superdex 200 HR 10/30
gel filtration column as described above. Similar experiments were also
performed with ferric EDTA and transferrin. Controls were as indicated
under "Results."
TRAP Generates ROS--
TRAP and EDTA-chelated iron were
approximately equally potent in facilitating ·OH formation from
H2O2, whereas transferrin did not generate
·OH in the deoxyribose system (Fig.
1A). Two zinc-containing
osteoclast enzymes involved in bone resorption, CA II and MMP-9, were
also unable to generate ·OH (Fig. 1B). The results
shown in Fig. 1B were not affected if protease inhibitors
were omitted from the reaction mixture (data not shown). The ·OH
scavenger mannitol decreased the amount of MDA formation in the
presence of TRAP (data not shown). We calculated the rate constant for
the reaction of mannitol with ·OH as described earlier (17) and
obtained a value of 1.7 × 109
M Intracellular Localization of TRAP in Osteoclasts--
We studied
the distribution of TRAP in resorbing osteoclasts and noticed that TRAP
was not localized in RB (Fig. 2,
A and B). Instead, it was co-localized to
intracellular vesicles containing endocytosed organic bone degradation
products released from bone matrix during resorption (Fig.
2C; see Ref. 7).
ROS Generated by TRAP Destroy Type I Collagen--
On the basis of
TRAP's capacity to facilitate ROS formation and its localization in
the transcytotic vesicles, we hypothesized that ROS generated by TRAP
could directly damage type I collagen and other proteins. To test the
hypothesis, we used the same conditions in demonstrating the generation
of hydroxyl radicals by TRAP (see Fig. 1A) and replaced
deoxyribose with type I collagen. The Mr of type I
collagen incubated in the reaction mixture without trap was > 1000, and the Mr of trap
incubated without type I collagen was 32 (data not shown). When type I
collagen and trap were incubated together without H2O2,
their Mr did not change (Fig. 3A). The addition of H2O2 resulted in fragmentation of most of
the type I collagen into small fragments with Mr
<10, whereas the Mr of trap did not change (Fig.
3B). Experiments in which albumin was used instead of
collagen revealed similar results (data not shown). Similarly to TRAP,
EDTA-chelated iron efficiently destroyed collagen, whereas transferrin
had no effect (data not shown), as suggested based on the deoxyribose
test (see Fig. 1A).
Osteoclasts take up resorbed bone material, which is transported
through the cell and secreted through FSD (6, 7). This transcytotic
route explains how osteoclasts are able to remove large amounts of
matrix degradation products and simultaneously penetrate into bone. We
show here that in resorbing osteoclasts, TRAP is localized in
transcytotic vesicles and not in RB or in the resorption lacuna. Our
results are in good agreement with those published earlier by Clark and
co-workers (25), who demonstrated by immunoelectron microscopy that
TRAP is localized in large cytoplasmic vesicles and not in RB. We
suggest that TRAP-containing vesicles from the biosynthetic pathway are
fused to transcytotic vesicles transporting matrix degradation products
from RB to FSD, where the enzyme is secreted together with the matrix
degradation products. Based on our results, we hypothesize that the
physiological function of TRAP in osteoclasts is to destroy endocytosed
matrix degradation products during their transcytosis. Thus, matrix
degradation would occur not only extracellularly in the resorption
lacunae but also intracellularly in the transcytotic vesicles.
TRAP knock-out mice show disrupted endochondral ossification and mild
osteopetrosis (16). If our hypothesis were correct, TRAP would not have
any effect on the attachment of osteoclasts to bone in the normal bone
remodeling cycle. Nor would TRAP affect development of the RB,
acidification of the resorption lacuna, degradation of bone matrix in
the resorption lacunae, or endocytosis of dissolved bone material. The
only effect would be on the processing of the endocytosed matrix
components during transcytosis. Thus, inactivation of TRAP would most
probably result in only a small decrease in bone resorption, which
would be in good agreement with the observed mild osteopetrosis in TRAP
knock-out mice.
Bone resorption produces various breakdown products of bone matrix
components into serum and urine (26). Clinical studies indicate that
stimulated bone resorption leads to increased levels of TRAP in the
serum (23, 27, 28), suggesting that osteoclasts would secrete TRAP into
the circulation during bone resorption, where it is found intact in a
large calcium-containing complex (28). Our results show that
TRAP-facilitated ROS formation leads to fragmentation of collagen and
other proteins. However, TRAP molecules themselves are not targets for
this fragmentation. This result is in accordance with the in
vivo findings that matrix proteins such as collagen, but not TRAP,
are found as small fragments in the circulation (26, 28).
Our results clearly demonstrate that TRAP is capable of generating ROS
that can destroy proteins in vitro. This activity of TRAP
was not inhibited by protease inhibitors, and a similar activity was
not observed in the same conditions for transferrin, an iron-containing protein without redox-active iron, and for CA II and MMP-9, two zinc-containing osteoclast enzymes involved in bone resorption. Instead, a similar activity was observed for EDTA-chelated redox-active iron. These observations suggest that the redox-active iron in TRAP
would be active in generating ROS. The fact that the TRAP over-expressing cells produce high amounts of ROS further supports this
hypothesis, although it is possible that some amount of the ROS in the
cells is generated because of cell damage.
Iron-catalyzed ·OH formation from hydrogen peroxide by the
Fenton reaction is well known to cause DNA damage (29). Hydroxyl radicals also affect proteins by destroying the peptide backbone and by
attacking some amino acid side chains, resulting in the fragmentation
of proteins and the formation of aggregates (30, 31). Instead,
·OH in combination with the superoxide anion (O In addition to osteoclasts, activated macrophages such as alveolar
macrophages of the lung express high amounts of TRAP in normal human
tissues (11). We have reported earlier that the enzymes purified from
these two cell types have identical catalytic properties, suggesting
that TRAP would have a similar physiological function in both
osteoclasts and macrophages (18). The transcytotic route in osteoclasts
represents a transport route from a late-endosome or lysosome-type
compartment (RB membrane) to the cell surface. Another example of such
a route is the transport route operating during antigen processing
before presentation in macrophages. The mechanisms involved in antigen
processing are not known. We hypothesize that TRAP could function in
activated macrophages in the antigen presentation route generating ROS
that would be targeted in antigen processing.
The role of ROS in the physiological degradation of the extracellular
matrix and in tissue remodeling is unknown. Our results demonstrate
that in specific cellular compartments of osteoclasts, TRAP-facilitated
ROS production can be targeted to destroy extracellular matrix
proteins. We propose that the family of proteins containing redox-active iron could represent a novel mechanism of physiological fragmentation in organic molecules. This mechanism could be important in tissue remodeling and as a defense mechanism of phagocytosing cells.
*
This work was supported by grants from the Academy of
Finland, State Technology Development Center of Finland (TEKES), and the Sigrid Juselius Foundation. World Health Organization Collaborating Center for Research on Reproductive Health is supported by the Ministry
of Education, Social Affairs and Health and the Ministry of Foreign
Affairs, Finland.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§§
To whom correspondence should be addressed. Tel.: 358-2-333 7232;
Fax: 358-2-333 7352; E-mail: kalervo.vaananen@utu.fi.
The abbreviations used are:
RB, ruffled border;
FSD, functional secretory domain;
ROS, reactive oxygen species;
TRAP, tartrate-resistant acid phosphatase;
MDA, malondialdehyde acetal;
CA
II, carbonic anhydrase II;
MMP-9, matrix metalloproteinase 9;
DCFH-DA, 2',7'-dichlorofluorescin diacetate.
COMMUNICATION
Intracellular Fragmentation of Bone Resorption Products by
Reactive Oxygen Species Generated by Osteoclastic Tartrate-resistant
Acid Phosphatase*
,
,
,
,
, and
§§
Institute of Biomedicine, Department of
Anatomy, University of Turku, FIN-20520 Turku, Finland,
§ Department of Orthopaedics and Traumatology, Helsinki
University Central Hospital, FIN-00260 Helsinki, Finland,
¶ Department of Medicine and Hematology, University of Texas
Health Science Center, San Antonio, Texas 78284-7880,
Bone and
Mineral Centre, The Rayne Institute, London WC1E 6JJ, United Kingdom,
** Biocenter Oulu and World Health Organization Collaborating Centre for
Research on Reproductive Health, University of Oulu, FIN-90220 Oulu,
Finland, and §§ Department of Biosciences,
University of Helsinki, FIN-00014 Helsinki, Finland
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
/
mice revealed mild osteopetrosis (excess accumulation of
bone) despite having a normal number and morphology of osteoclasts
(16). To learn the physiological function of TRAP, we hypothesized that
TRAP could facilitate the formation of ·OH and target those
·OH to break down extracellular matrix components during bone resorption.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1 s
1, which is in accordance
with the rate constant 1.0-2.0 × 109
M
1 s
1 obtained earlier for
mannitol using EDTA-chelated iron as a generator of ·OH in the
deoxyribose system (17). RAW-264 cells over-expressing TRAP had a
significantly higher basal production of ROS than their parent cells
(Fig. 1C).

View larger version (17K):
[in a new window]
Fig. 1.
TRAP generates hydroxyl radicals.
A, the ability of EDTA-chelated iron, recombinant rat bone
TRAP, and transferrin to generate ·OH was detected by measuring
the formation of MDA from deoxyribose fragments in the presence of
H2O2. A532, which is
directly proportional to the amount of MDA formed versus the
amount of iron (µM) present in each measurement, is
given. B, comparison of the ability of TRAP, CA II, and
MMP-9 to generate ·OH. A532 after each
reaction is shown. C, RAW-264 cells over-expressing TRAP
have significantly higher basal production of intracellular ROS than
their parent cells. Intracellular ROS were detected from 50 RAW-264
cells over-expressing TRAP and from 50 of their parent cells using the
fluorescent probe DCFH-DA. The mean ± S.D. of relative optical
density (ROD) of intracellular fluorescence is given.

View larger version (29K):
[in a new window]
Fig. 2.
Laser scanning confocal microscopy was used
to study the localization of TRAP in resorbing osteoclasts.
A and B, double staining of resorbing osteoclasts
by TRAP and PNA-lectin demonstrated the following: the upper
part of the cells contains numerous large TRAP-containing vesicles
(A, red color, indicated by
arrows), which are not found in the ruffled
border area stained by PNA-lectin (B, green
color). C, to reveal the presence of intracellular
organic bone degradation products, osteoclasts were cultured on
biotinylated bone slices (7). Double-staining of TRAP (red
color) with biotin (green color) revealed several large
intracellular vesicles with co-localization (yellow color,
indicated by arrows). Dotted lines indicate cell
borders (A-C). Scale bars (B and
C) = 10 µm.

View larger version (9K):
[in a new window]
Fig. 3.
HPLC Superdex 200 gel filtration was used to
study the ability of ·OH formed by recombinant TRAP to destroy
type I collagen. A, when type I collagen and TRAP were
incubated together without H2O2, type I
collagen eluted in the void volume, and trap eluted in fractions
corresponding with Mr 32. B, the addition
of H2O2 resulted in fragmentation of most of
the type I collagen to small fragments with Mr < 10, whereas TRAP still eluted as described in A.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
2) cause
protein fragmentation without the formation of aggregates (30). Our results demonstrate the fragmentation of proteins by ·OH
generated by TRAP without aggregate formation, suggesting that O
2 would also be present in the reaction mixture. When the
redox-active iron in the binuclear iron center of TRAP is in the
ferrous form, it can react with H2O2 by the
Fenton reaction to produce a ferric ion and ·OH:
Fe2+ + H2O2
Fe3+ + OH-+ ·OH. The newly formed ferric ion is still
redox-active and able to react with H2O2 to
form O
2 and a ferrous ion: Fe3+ + H2O2
Fe2+ + 2 H+ + O
2. The formed ferrous ion is again able to react by the
Fenton reaction etc. Thus, a sequence of reactions generating both
·OH and O
2 occurs with continuous oxidation and
reduction of the redox-active iron, making it possible for one enzyme
molecule to generate a high number of these ROS as long as
H2O2 is available.
![]()
FOOTNOTES
![]()
ABBREVIATIONS
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1.
Blair, H. C.,
Kahn, A. J.,
Crouch, E. C.,
Jeffrey, J. J.,
and Teitelbaum, S. L.
(1986)
J. Cell Biol.
102,
1164-1172 2.
Baron, R.,
Neff, L.,
Brown, W.,
Courtoy, P. J.,
Louvard, D.,
and Farquhar, M. G.
(1988)
J. Cell Biol.
106,
1863-1872 3.
Blair, H. C.,
Teitelbaum, S. L.,
Ghiselli, R.,
and Gluck, S.
(1989)
Science
245,
855-857 4.
Väänänen, H. K.,
Karhukorpi, E. K.,
Sundquist, K.,
Wallmark, B.,
Roininen, I.,
Hentunen, T.,
Tuukkanen, J.,
and Lakkakorpi, P.
(1990)
J. Cell Biol.
111,
1305-1311 5.
Väänänen, H. K.
(1996)
in
Principles of Bone Biology
(Bilezikian, J. P.
, Raisz, L. G.
, and Rodan, G. A., eds)
, pp. 103-113, Academic Press, San Diego, CA
6.
Nesbitt, S. A.,
and Horton, M. A.
(1997)
Science
276,
266-269 7.
Salo, J. J.,
Lehenkari, P.,
Mulari, M.,
Metsikkö, K.,
and Väänänen, H. K.
(1997)
Science
276,
270-273 8.
Salo, J.,
Metsikkö, K.,
Palokangas, H.,
Lehenkari, P.,
and Väänänen, H. K.
(1996)
J. Cell Sci.
106,
301-307
9.
Silverton, S.
(1994)
J. Cell. Biochem.
56,
367-373[CrossRef][Medline]
[Order article via Infotrieve]
10.
Minkin, C.
(1982)
Calcif. Tissue Int.
34,
285-290[CrossRef][Medline]
[Order article via Infotrieve]
11.
Yaziji, H.,
Janckila, A. J.,
Lear, S. C.,
Martin, A. W.,
and Yam, L. T.
(1995)
Am. J. Clin. Pathol.
104,
397-402[Medline]
[Order article via Infotrieve]
12.
Davis, J. C.,
and Averill, B. A.
(1982)
Proc. Natl. Acad. Sci. U. S. A.
79,
4623-4627 13.
Doi, K.,
Antanaitis, B. C.,
and Aisen, P.
(1988)
Struct. Bonding
70,
1-26
14.
Sibille, J.-C.,
Doi, K.,
and Aisen, P.
(1987)
J. Biol. Chem.
262,
59-62 15.
Hayman, A. R.,
and Cox, T. M.
(1994)
J. Biol. Chem.
269,
1294-1300 16.
Hayman, A. R.,
Jones, S. J.,
Boyde, A.,
Foster, D.,
Colledge, W. H.,
Carlton, M. B.,
Evans, M. J.,
and Cox, T. M.
(1996)
Development
122,
3151-3162[Abstract]
17.
Halliwell, B.,
Gutteridge, J. M. C.,
and Aruoma, O. I.
(1987)
Anal. Biochem.
165,
215-219[CrossRef][Medline]
[Order article via Infotrieve]
18.
Halleen, J. M.,
Kaija, H.,
Stepan, J. J.,
Salo, J. J.,
Vihko, P.,
and Väänänen, H. K.
(1998)
Arch. Biochem. Biophys.
352,
97-102[CrossRef][Medline]
[Order article via Infotrieve]
19.
Vihko, P.,
Kurkela, R.,
Porvari, K.,
Herrala, A.,
Lindfors, A.,
Lindqvist, Y.,
and Schneider, G.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
799-803 20.
Ohba, M.,
Shibanuma, M.,
Kuroki, T.,
and Nose, K.
(1994)
J. Cell Biol.
126,
1079-1088 21.
Lehenkari, P. P.,
Laitala-Leinonen, T.,
Linna, T.-J.,
and Väänänen, H. K.
(1997)
Biochem. Biophys. Res. Commun.
235,
838-844[CrossRef][Medline]
[Order article via Infotrieve]
22.
Lakkakorpi, P. T.,
Tuukkanen, J.,
Hentunen, T.,
Järvelin, K.,
and Väänänen, K.
(1989)
J. Bone Miner. Res.
4,
817-825[Medline]
[Order article via Infotrieve]
23.
Halleen, J.,
Hentunen, T. A.,
Hellman, J.,
and Väänänen, H. K.
(1996)
J. Bone Miner. Res.
11,
1444-1452[Medline]
[Order article via Infotrieve]
24.
Takagi, M.,
Yakasaki, H.,
and Baba, H.
(1988)
J. Histochem. Cytochem.
36,
95-101[Abstract]
25.
Clark, SA,
Ambrose, W. W.,
Anderson, T. R.,
Terell, R. S.,
and Toverud, S. U.
(1989)
J. Bone Miner. Res.
4,
399-405[Medline]
[Order article via Infotrieve]
26.
Garnero, P.,
and Delmas, P. D.
(1996)
in
Principles of Bone Biology
(Bilezikian, J. P.
, Raisz, L. G.
, and Rodan, G. A., eds)
, pp. 1277-1291, Academic Press, San Diego, CA
27.
Kraenzlin, M. E.,
Lau, K. H. W.,
Liang, L.,
Freeman, T. K.,
Singer, F. R.,
Stepan, J.,
and Baylink, D. J.
(1990)
J. Clin. Endocrinol. Metab.
71,
442-451[Abstract]
28.
Halleen, J. M.,
Hentunen, T. A.,
Karp, M.,
Käkönen, S.-M.,
Pettersson, K.,
and Väänänen, H. K.
(1998)
J. Bone Miner. Res.
13,
683-687[CrossRef][Medline]
[Order article via Infotrieve]
29.
Henle, E. S.,
and Linn, S.
(1997)
J. Biol. Chem.
272,
19095-19098 30.
Davies, K. J. A.,
and Delsignore, M. E.
(1987)
J. Biol. Chem.
262,
9908-9913 31.
Berlett, B. S.,
and Stadtman, E. R.
(1997)
J. Biol. Chem.
272,
20313-20316
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
M. J. Valimaki and R. Tahtela Serum Tartrate-Resistant Acid Phosphatase 5b or Amino-Terminal Propeptide of Type I Procollagen for Monitoring Bisphosphonate Therapy in Postmenopausal Osteoporosis? Clin. Chem., December 1, 2005; 51(12): 2382 - 2385. [Full Text] [PDF] |
||||
![]() |
J. Ljusberg, Y. Wang, P. Lang, M. Norgard, R. Dodds, K. Hultenby, B. Ek-Rylander, and G. Andersson Proteolytic Excision of a Repressive Loop Domain in Tartrate-resistant Acid Phosphatase by Cathepsin K in Osteoclasts J. Biol. Chem., August 5, 2005; 280(31): 28370 - 28381. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. J. Pavlos, J. Xu, D. Riedel, J. S. G. Yeoh, S. L. Teitelbaum, J. M. Papadimitriou, R. Jahn, F. P. Ross, and M. H. Zheng Rab3D Regulates a Novel Vesicular Trafficking Pathway That Is Required for Osteoclastic Bone Resorption Mol. Cell. Biol., June 15, 2005; 25(12): 5253 - 5269. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E.T. da Costa, N. E. Annels, C. M.J.M. Faaij, R. G. Forsyth, P. C.W. Hogendoorn, and R. M. Egeler Presence of osteoclast-like multinucleated giant cells in the bone and nonostotic lesions of Langerhans cell histiocytosis J. Exp. Med., March 7, 2005; 201(5): 687 - 693. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Janckila, R. N. Parthasarathy, L. K. Parthasarathy, R. S. Seelan, Y.-C. Hsueh, J. Rissanen, S. L. Alatalo, J. M. Halleen, and L. T. Yam Properties and expression of human tartrate-resistant acid phosphatase isoform 5a by monocyte-derived cells J. Leukoc. Biol., February 1, 2005; 77(2): 209 - 218. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Alatalo, K. K. Ivaska, S. G. Waguespack, M. J. Econs, H. K. Vaananen, and J. M. Halleen Osteoclast-Derived Serum Tartrate-Resistant Acid Phosphatase 5b in Albers-Schonberg Disease (Type II Autosomal Dominant Osteopetrosis) Clin. Chem., May 1, 2004; 50(5): 883 - 890. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. W. Dwyer, P. P. Provenzano, P. Muir, W. B. Valhmu, and R. Vanderby Jr. Blockade of the sympathetic nervous system degrades ligament in a rat MCL model J Appl Physiol, February 1, 2004; 96(2): 711 - 718. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. A. J. van de Loo, M. B. Bennink, O. J. Arntz, R. L. Smeets, E. Lubberts, L. A. B. Joosten, P. L. E. M. van Lent, C. J. J. Coenen-de Roo, S. Cuzzocrea, B. H. Segal, et al. Deficiency of NADPH Oxidase Components p47phox and gp91phox Caused Granulomatous Synovitis and Increased Connective Tissue Destruction in Experimental Arthritis Models Am. J. Pathol., October 1, 2003; 163(4): 1525 - 1537. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Janckila, W.-K. Yang, R.-J. Lin, C.-J. Tseng, H.-Y. Chang, J.-M. Chang, and L. T. Yam Flow Cytoenzymology of Intracellular Tartrate-resistant Acid Phosphatase J. Histochem. Cytochem., September 1, 2003; 51(9): 1131 - 1135. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Liu, Z. Shi, A. Silveira, J. Liu, M. Sawadogo, H. Yang, and X. Feng Involvement of Upstream Stimulatory Factors 1 and 2 in RANKL-induced Transcription of Tartrate-resistant Acid Phosphatase Gene during Osteoclast Differentiation J. Biol. Chem., May 30, 2003; 278(23): 20603 - 20611. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. G. Waguespack, S. L. Hui, K. E. White, K. A. Buckwalter, and M. J. Econs Measurement of Tartrate-Resistant Acid Phosphatase and the Brain Isoenzyme of Creatine Kinase Accurately Diagnoses Type II Autosomal Dominant Osteopetrosis but Does Not Identify Gene Carriers J. Clin. Endocrinol. Metab., May 1, 2002; 87(5): 2212 - 2217. [Abstract] [Full Text] [PDF] |
||||
![]() |
H Bull, P G Murray, D Thomas, A M Fraser, and P N Nelson Acid phosphatases Mol. Pathol., April 1, 2002; 55(2): 65 - 72. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Hayman, P. Macary, P. J. Lehner, and T. M. Cox Tartrate-resistant Acid Phosphatase (Acp 5): Identification in Diverse Human Tissues and Dendritic Cells J. Histochem. Cytochem., June 1, 2001; 49(6): 675 - 684. [Abstract] [Full Text] |
||||
![]() |
S. L. Alatalo, J. M. Halleen, T. A. Hentunen, J. Monkkonen, and H. K. Vaananen Rapid Screening Method for Osteoclast Differentiation in Vitro That Measures Tartrate-resistant Acid Phosphatase 5b Activity Secreted into the Culture Medium Clin. Chem., November 1, 2000; 46(11): 1751 - 1754. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Hayman, A. J. Bune, J. R. Bradley, J. Rashbass, and T. M. Cox Osteoclastic Tartrate-resistant Acid Phosphatase (Acp 5): Its Localization to Dendritic Cells and Diverse Murine Tissues J. Histochem. Cytochem., February 1, 2000; 48(2): 219 - 228. [Abstract] [Full Text] |
||||
![]() |
H. Vaananen, H Zhao, M Mulari, and J. Halleen The cell biology of osteoclast function J. Cell Sci., January 2, 2000; 113(3): 377 - 381. [Abstract] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |